Expression of the Retinoblastoma Tumor Suppressor Gene (RB-1) in Acute Leukemia

References

• Marshall C. J. Tumor suppressor genes. Cell 1991; 64: 313–326
   PubMed Web of Science ®Google Scholar
• Vramus H. E., Lowell C. A. Cancer genes and hematopoiesis. Blood 1994; 83: 5–9
   PubMed Web of Science ®Google Scholar
• Yarbo J. W. Oncogenes and cancer suppressor genes. Semin. Oncol. 1992; 8: 30–39
   Google Scholar
• Godbout R., Dryja T. P., Squire J., Gallie B. L., Phillips R. A. Somatic inactivation of genes on chromosome 13 is a common event in both hereditary and non-hereditary retinoblastoma tumors. Nature 1983; 304: 451–455
   PubMed Web of Science ®Google Scholar
• Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–649
   PubMed Web of Science ®Google Scholar
• Toguchida J., Ishizak K., Sasaki M. S., Ikenaga M., Sugimoto M., Kotoura Y., Yamamuro T. Chromosomal reorganization for the expression of recessive mutation of the retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res. 1988; 48: 3939–3943
   PubMed Web of Science ®Google Scholar
• Benedict W. F., Xu H. J., Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J. Clin. Invest. 1990; 85: 988–993
   PubMed Web of Science ®Google Scholar
• Presti J. C., Reuter V. C., Galan T., Fai W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res. 1991; 51: 5405–5409
   PubMed Web of Science ®Google Scholar
• Pietilainen T., Lipponen P., Aaltomaa S., Eskelinen M., Kosma V. M., Syrjanen K. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur. J. Cancer 1995; 31: 329–333
   Web of Science ®Google Scholar
• Cance W. G., Brennan M. F., Dudas M. E., Huang C.-M., Cordon-Cardo C. Alterated expression of the retinoblastoma gene product in human sarcomas. New. Engl. J. Med 1990; 323: 1457–1459
   PubMed Web of Science ®Google Scholar
• Zuckerberg L. R., Benedict W. F., Arnold A., Dyson N., Harlow E., Harris L. H. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1. Blood, 88: 268–276
   PubMed Web of Science ®Google Scholar
• Weide R., Tiemann M., Pfliiger K.-H., Koppler H., Parvizl B., Wacker H. H., Kreipe H. H., Havemann K., Parwaresch M. R. Alterated expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994; 8: 97–101
   PubMed Web of Science ®Google Scholar
• Paggi M. G., Defrabitiis P., Bonetto F., Amadio L., Santarelli G., Spadea A., Gentile F. P., Floridi A., Felsani A. The retinoblastoma gene product in acute myeloid leukemia. A possible involvement in acute promyelo-cytic leukemia. Cancer Res. 1995; 55: 4552–4556
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Jat P. S., Foti A., Bar-Eli M., Cline M. J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu H.-J., del Giglio A., Hu S. X., Zhang W., Calvert L., Beran M., Estey E., Andreeff M., Trujillo J., Cork M. A., Smith T. L., Benedict W. F., Deisseroth A. B. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res. 1992; 52: 4587–4590
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu H. J. X., Zhang W., Hu S. X., Beran M., Smith T. L., Hester J., Estey E., Benedict W. F., Deisseroth A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994; 84: 256–261
   PubMed Web of Science ®Google Scholar
• Tang J. L., Yeh S. H., Chen P. J., Lin M. T., Tien H.-F., Chen Y. C. Inactivation of the retinoblastoma gene in acute myelogenous leukemia. Br. J. Haematol. 1992; 82: 502–507
   PubMed Web of Science ®Google Scholar
• Sauerbrey A., Stammler G., Zintl F., Volm M. Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukemia. Br. J. Haematol 1996; 94: 99–104
   PubMed Web of Science ®Google Scholar
• Hangaishi A., Ogawa S., Imamura N., Miyawaki S., Miura Y., Uike N., Shimazaki C., Emi N., Takeyama K., Hirosawa S., Kamada N., Kobayashi Y., Takemoto Y., Kitani T., Toyama K., Ohtake S., Yazaki Y., Ueda R., Hirai H. Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 1996; 87: 4949–4958
   PubMed Web of Science ®Google Scholar
• Horton L. E., Qian Y., Templeton D. J. G1 cyclin controls the retinoblastoma gene product regulation activity via upstream mechanisms. Cell Growth Differ. 1995; 6: 395–407
   PubMedGoogle Scholar
• Goodrich D. W., Wang N. P., Qian Y. W., Lee E. Y. H. P., Lee W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991; 67: 293–302
   PubMed Web of Science ®Google Scholar
• Lipponen P., Eskelinen M., Syrjanen K. Expression of tumor-suppressor gene Rb, apoptosis-suppress-ing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br. J. Cancer 1995; 71: 863–867
   PubMed Web of Science ®Google Scholar
• Udvadia A. J., Templeton D. J., Horowitz J. M. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: Superactivation by Rb requires amino acids necessary for growth suppression. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 3953–3957
   PubMed Web of Science ®Google Scholar
• Robbins P. D., Horowitz J. M., Mulligan R. C. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 1990; 346: 668–672
   PubMed Web of Science ®Google Scholar
• Lukas J., Bartkova J., Rohde M., Strauss M., Bartek J. Cyclin Dl is dispensable forGI control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell Biol. 1995; 15: 2600–2611
   PubMed Web of Science ®Google Scholar
• Whyte P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene: The adenovirus E1 A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124–129
   PubMed Web of Science ®Google Scholar
• De Caprio J. A., Ludlow J. W., Figge J., Shew J.-Y., Huang C. M., Lee W.-H., Marsilio E., Paucha E., Livingston D. M. SV 40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–280
   PubMed Web of Science ®Google Scholar
• Zintl F., Malke H., Reimann M., Domula M., Dörffel W., Eggers G., Exadaktylos P., Hilgenfeld E., Kotte W., Krause I., Kunert W., Mittler U., Mobius D., Reddemann H., Weinmann G., Wei???bach G. Results with ran-domized BFM adopted studies for ALL therapy in childhood in east German countries. Acute Leukemias IV: Prognostic factors, T. Büchner, G. Schellong, W. Hiddemann, J. Urbanitz, J. Ritter. Springer Verlag, Berlin Heidelberg 1993; 179–186
   Google Scholar
• Tsai T., Davalath S., Rankin C., Radich J. P., Head D., Appelbaum F. R., Boldt D. H. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia 1996; 10: 1901–1910
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 11: 833–840
   Google Scholar
• Weide R., Parviz B., Plüge K. H., Havemann K. Alterated expression of the human retinoblastoma gene in monocytic leukemias. Br. J. Haematol 1993; 83: 428–432
   PubMed Web of Science ®Google Scholar
• Neubauer A., de Kant E., Rochlitz C., Laser J., Zanetta A. M., Gallardo J., Oertel J., Herrmann R., Huhn D. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukemia. Br. J. Haematol. 1993; 85: 498–503
   PubMed Web of Science ®Google Scholar
• Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Boccadoro M., Pileri A., Dalla-Favera R. Inactivation of tumor suppressor genes, p53 and Rbl, in plasma cell dyscrasias. leukemia 1994; 8: 758–767
   PubMed Web of Science ®Google Scholar
• Gorlick R., Goker E., Trippett T., Waltham M., Benerjee D., Bertino J. R. Intrinsic and acquired resistance to methotrexate in acute leukemia. N. Engl. J. Med. 1996; 335: 1041–1048
   PubMed Web of Science ®Google Scholar
• Volm M., Mattern J., Samsel B. Relationship of inherited resistance to doxorubicin, proliferative activity and expression of p-glycoprotein 170, and glutathione S-trans-ferase π in human lung tumors. Cancer 1992; 70: 764–769
   PubMed Web of Science ®Google Scholar
• Volm M., Sauerbrey A., Stammler G., Zintl F. Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and PCR. Int. J. Oncology 1994; 4: 1251–1256
   PubMed Web of Science ®Google Scholar
• Sauerbrey A., Zintl F., Volm M. P-glycoprotein and glutathione S-transferase π in childhood acute lymphoblastic leukemia. Br. J. Cancer 1994; 70: 1144–1149
   PubMed Web of Science ®Google Scholar